Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway

Genes and Development

Volumn 11, Issue 24, 1997, Pages 3351-3364

  Caelles, Carme ^a,b   González Sancho, José M ^a   Muñoz, Alberto ^a  

^a CSIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

AP 1; JNK SAPK; Nuclear hormone receptors; Protein phosphorylation; Signal transduction

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CELL NUCLEUS RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DACTINOMYCIN; DEXAMETHASONE; HORMONE RECEPTOR; IMMUNOSUPPRESSIVE AGENT; PROTEIN KINASE; RECEPTOR BLOCKING AGENT; RETINOID; STEROID HORMONE; STEROID RECEPTOR; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

ANIMALIA; CERVUS ELAPHUS;

EID: 0031455626     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.24.3351     Document Type: Article

References (85)

1. Angel, P. and M. Karin. 1991. The role of Jun, Fos, and the AP-1 complex in cell proliferation and transformation. Biochem. Biophys. Acta 1072: 129-157.
2. Angel, P., M. Imagawa, R. Chiu, B. Stein, R.J. Imbra, H.J. Rahmsdor, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognised by a TPA-modulated trans-acting factor. Cell 49: 729-739.
3. Angel, P., E.A. Allegretto, S.T. Okino, K. Hattori, W.J. Boyle, T. Hunter, and M. Karin. 1988. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature 332: 166-171.
4. Arias, J., A.S. Alberts, P. Brindle, F.X. Claret, T. Smeal, M. Karin, J. Feramisco, and M. Montminy. 1994. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370: 226-229.
5. Auphan, N., J.A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosupression by glucocorticoids: Inhibition of NK-κB activity through induction of IκB synthesis. Science 270: 286-290.
6. Ausubel, F.M., R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Strul. 1994. Current protocols in molecular biology, Greene Publishing Associates/Wiley-Interscience, New York, NY.
7. Bannister, A.J., T. Oehler, D. Wilhelm, P. Angel, and T. Kouzarides. 1995. Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene 11: 2509-2514.
8. Black, E.J., A.D. Catling, J.R. Woodgett, A. Kilbey, and D.A.F. Gillespie. 1994. Transcriptional activation by the v-Jun oncoprotein is independent of positive regulatory phosphorylation. Oncogene 9: 2363-2368.
9. Bohmann, D., T.J. Bos, A. Admon, T. Nishimura, P.K. Vogt, and R. Tjian. 1987. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 238: 1386-1392.
10. Brenner, D.A., M. O'Hara, P. Angel, M. Chojkier, and M. Karin. 1989. Prolonged activation of jun and collagenase genes by tumor necrosis factor α. Nature 337: 661-663.
11. Caelles, C., H. Hennemann, and M. Karin. 1995. M-phase-specific phosphorylation of the POU transcription factor GHF-1 by a cell cycle-regulated protein kinase inhibits DNA binding. Mol. Cell. Biol. 15: 6694-6701.
12. Cahill, M.A., R. Janknecht, and A. Nordheim. 1996. Signaling pathways: Jack of all cascades. Curr. Biol. 6: 16-19.
13. Cavigelli, M., F. Dolfi, F.X. Claret, and M. Karin. 1995. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J. 14: 5957-5964.
14. Chakravarti, D., V.J. LaMorte, M.C. Nelson, T. Nakajima, LG. Schulman, H. Juguilon, M. Montminy, and R.M. Evans. 1996. Role of CBP/p300 in nuclear receptor signaling. Nature 383: 99-103.
15. Chen, J.Y., S. Penco, J. Ostrowski, P. Balaguer, M. Pons, J.E. Starrett, P. Reczek, P. Chambon, and H. Gronemeyer. 1995. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J. 14: 1187-1197.
16. Chu, Y., P.A. Solski, R. Khosravi-Far, C.J. Der, and K. Kelly. 1996. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 seven-maker mutation. J. Biol. Chem. 271: 6497-6591.
17. Cosso, O.A., M. Chiariello, J.C. Yu, H. Teramoto, P. Crespo, N. Xu, T. Miki, and J.S. Gutkind. 1995. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/ SAPK signaling pathway. Cell 81: 1137-1146.
18. Crespo, P., K.E. Schuebel, A.A. Ostrom, J.S. Gutkind, and X.R. Bustelo. 1997. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385: 169-172.
19. Czar, M.J., R.H. Lyons, M.J. Welsh, J.M. Renoir, and W.B. Pratt. 1995. Evidence that the FK506-binding immunophilin heat shock protein 56 is required for trafficking of the glucocorticoid receptor from the cytoplasm to the nucleus. Mol. Endocrinol. 9: 1549-1560.
20. Dérijard, B., M. Hibi, I.H. Wu, T. Barret, B. Su, T. Deng, M. Karin, and R.J. Davis. 1994. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76: 1025-1037.
21. Desbois, C., D. Aubert, C. Legrand, B. Pain, and J. Samarut. 1991. A novel mechanism of action for v-ErbA: Abrogation of the inactivation of transcription factor AP-1 by retinoic acid and thyroid hormone receptors. Cell 67: 731-740.
22. Devary, Y., R.A. Gottlieb, L.F. Lau, and M. Karin. 1991. Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol. Cell. Biol. 11: 1804-2811.
23. Devary, Y., R.A. Gottlieb, T. Smeal, and M. Karin. 1992. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 71: 1081-1091.
24. Dikic, I., J. Schlessinger, and I. Lax. 1994. PC12 cell overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation. Curr. Biol. 4: 702-708.
25. Fanjul, A., M.I. Dawson, P.D. Hobbs, L. Jong, J.F. Cameron, E. Harlev, G. Graupner, X.P. Lu, and M. Pfahl. 1994. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 372: 107-110.
26. Gille, H., T. Strahl, and P.E. Shaw. 1995. Activation of ternary complex factor Elk-1 by stress-activated protein kinases. Curr. Biol. 5: 1191-1200.
27. Gupta, S., D. Campbell, B. Dérijard, and R.J. Davis. 1995. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267: 389-393.
28. Helmberg, A., N. Auphan, C. Caelles, and M. Karin. 1995. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J. 14: 452-460.
29. Herrera, R.E., P.E. Shaw, and A. Nordheim. 1989. Occupation of the c-fos serum response element in vivo by a multi-protein complex is unaltered by growth factor induction. Nature 340: 68-70.
30. Hibi, M., A. Lin, T. Smeal, A. Minden, and M. Karin. 1993. Identification of an oncoprotein-and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes &. Dev. 7: 2135-2148.
31. TCF. Nature 354: 531-534.
32. Hirano, M., S. Osada, T. Aoki, S. Hirai, M. Hosaka, J. Inoue, and S. Ohno. 1996. MEK kinase is involved in tumor necrosis factor α-induced NF-κB activation and degradation of IκB-α. J. Biol. Chem. 271: 13234-13238.
33. Htun, H., J. Barsony, I. Renyi, D.L. Gould, and G.L. Hager. 1996. Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera. Proc. Natl. Acad. Sci. 93: 4845-4850.
34. Jiang, H., J. Lin, S. Zao-zohong, F.R. Collart, E. Huberman, and P.B. Fisher. 1994. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9: 3397-3346.
35. Jonat, C., H.J. Rahmsdorf, K.K. Park, A.C.B. Cato, S. Gebel, H. Ponta, and P. Herrlich. 1990. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62: 1189-1204.
36. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S.C. Lin, R.A. Heyman, D. Rose, C.K. Glass, and M.G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403-414.
37. Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270: 16483-16486.
38. Karin M. and T. Hunter. 1995. Transcriptional control by protein phosphorylation: Signal transmission from the cell surface to the nucleus. Curr. Biol. 5: 747-757.
39. Karin, M., Z. Liu, and E. Zandi. 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9: 240-246.
40. König, H., H. Ponta, H.J. Rahmsdorf, and P. Herrlich. 1992. Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J. 11: 2241-2246.
41. Kyriakis, J.M., P. Banerjee, E. Nikolakaki, T. Dai, E.A. Rubie, M.F. Ahmad, J. Avruch, and J.R. Woodgett. 1994. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369: 156-160.
42. Liu, Y., M. Gorospe, C. Yang, and N.J. Holbrook. 1995. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of c-Jun amino-terminal kinase activity and AP-1-dependent gene activation. J. Biol. Chem. 270: 8377-8380.
43. Livingstone, C., G. Patel, and N. Jones. 1995. ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J. 14: 1785-1797.
44. López-Barahona, M., I. Fialka, J.M. González-Sancho, M. Asunción, M. González, T. Iglesias, J. Bernal, H. Beug, and A. Muñoz. 1995. Thyroid hormone regulates stromelysin expression, protease secretion and the morphogenetic potential of normal polarized mammary epithelial cells. EMBO J. 14: 1145-1155.
45. Mangelsdorf, D.J., C. Thummel, M. Beato, P. Herrlich, G. Schütz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R.M. Evans. 1995. The nuclear receptor superfamily: The second decade. Cell 83: 835-839.
46. Meyer, C.F., X. Wang, C. Chang, D. Templeton, and T.H. Tan. 1996. Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating κB enhancer activation. J. Biol Chem. 271: 8971-8976.
47. ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15: 1292-1300.
48. Minden, A., A. Lin, T. Smeal, B. Dérijard, M. Cobb, R. Davis, and M. Karin. 1994a. c-Jun amino-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol. Cell. Biol. 14: 6683-6688.
49. Minden, A., A. Lin, M. McMahon, G.L. Lange-Carter, B. Dérijard, R.J. Davis, G.L. Johnson, and M. Karin. 1994b. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266: 1719-1723.
50. Minden, A., A. Lin, F.X. Claret, A. Abo, and M. Karin. 1995. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPase Rac and Cdc42Hs. Cell 81: 1147-1157.
51. Nicholson, R.C., S. Mader, S. Nagpal, M. Leid, C. Rochette-Egly, and P. Chambon. 1990. Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP-1 binding site. EMBO J. 9: 4443-4454.
52. Papavassiliou, A.G., M. Treier, and D. Bohmann. 1995. Intramolecular signal transduction in c-Jun. EMBO J. 14: 2014-2019.
53. Pulverer, B.J., J.M. Kyriakis, J. Avurch, E. Nikolakaki, and J.R. Woodgett. 1991. Phosphorylation of c-Jun mediated by MAP kinases. Nature 353: 670-674.
54. ras activity and consequent prolonged ERK activity. Neuron 9: 705-717.
55. Radler-Pohl, A., C. Sachsenmaier, S. Gebel, H.P. Auer, J.T. Bruder, U. Rapp, P. Angel, H.J. Rahmsdorf, and P. Herrlich. 1993. UV-induced activation of AP-1 involves obligatory extranuclear steps including Raf-1 kinase. EMBO J. 12: 1005-1012.
56. Cip1. Mol. Endocrinol. 11: 577-586.
57. Rhodes, S.J., R. Chen, G.E. DiMattia, K.M. Scully, K.A. Kalla, S.C. Lin, V.C. Yu, and M.G. Rosenfeld. 1993. A tissue-specific enhancer confers Pit-1-dependent morphogen inducibility and autoregulation of the pit-1 gene. Genes & Dev. 7: 913-932.
58. Robinson, M.J. and M.H. Cobb. 1997. Mitogen-activated protein kinase pathway. Curr. Opin. Cell Biol. 9: 180-186.
59. Rogatsky, I., J.M. Trowbridge, and M.J. Garabedian. 1997. Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. Mol. Cell. Biol. 17: 3181-3193.
60. Saatcioglu, F., P. Bartunek, T. Deng, M. Zenke, and M. Karin. 1993. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor). Mol. Cell. Biol. 13: 3675-3685.
61. Saatcioglu, F., F.X. Claret, and M. Karin. 1994. Negative transcriptional regulation by nuclear receptors. Semin. Cancer Biol. 5: 347-359.
62. Sachsenmaier, C., A. Radler-Pohl, R. Zinck, A. Nordheim, P. Herrlich, and H.J. Rahmsdorf. 1994. Involvement of growth factor receptors in the mammalian UVC response. Cell 78: 963-972.
63. Sánchez, I., R.J. Hughes, B.J. Mayer, K. Yee, J.R. Woodgett, J. Avruch, J.M. Kyriakis, and L.I. Zon. 1994. Role of SAPK/ ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 372: 794-798.
64. Scheinman, R.I., A. Gualberto, C.M. Jewel, J.A. Cidlowski, and A.S. Baldwin, Jr. 1995a. Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol. Cell. Biol. 15: 943-953.
65. Scheinman, R.I., P.C. Cogswell, A.K. Lofquist, and A.S. Baldwin, Jr. 1995b. Role of transcriptional activation of IκBα in mediation of immunosupression by glucocorticoids. Science 270: 283-286.
66. Schena, M., L.P. Freedman, and K.R. Yamamoto. 1989. Mutations in the glucocorticoid receptor zinc finger region that distinguish interdigitated DNA binding and transcriptional enhancement activities. Genes & Dev. 3: 1590-1601.
67. Schüle, R., P. Rangarajan, S. Kliewer, L.J. Ransone, J. Bolado, N. Yang, I.M. Verma, and R.M. Evans. 1990. Funtional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62: 1217-1226.
68. Schüle, R., P. Rangarnjan, N. Yang, S. Kliewer, L.J. Ransone, J. Bolado, I.M. Verma, and R.M. Evans. 1991. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc. Natl. Acad. Sci. 88: 6092-6096.
69. Shaw, P.E., H. Schröter, and A. Nordheim. 1989. The ability of a ternary complex to form over the serum response element correlates with serum inducibility of the human c-fos promoter. Cell 56: 563-572.
70. Shim, J., H. Lee, J. Park, H. Kim, and E.-J. Choi. 1996. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature 381: 804-807.
71. Smeal, T., B. Binetruy, D.A. Mercola, M. Birrer, and M. Karin. 1991. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354: 494-496.
72. Stein, B., H.J. Rahmsdorf, A. Steffetn, M. Liftin, and P. Herrlich. 1989. UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos, and metallothionein. Mol. Cell. Biol. 9: 5169-5181.
73. Traverse, S., K. Seedorf, H. Paterson, C.J. Marshall, P. Cohen, and A. Ullrich. 1994. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr. Biol. 4: 694-701.
74. Ucker, D.S. and K.R. Yamamoto. 1984. Early events in the stimulation of mammary tumor virus RNA synthesis by glucocorticoids. J. Biol. Chem. 259: 7416-7420.
75. van Dam, H., M. Duyndam, R. Rottier, A. Bosch, L. de Vries-Smits, P. Herrlich, A. Zantema, P. Angel, and A.J. van der Eb. 1993. Heterodimer formation of c-Jun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J. 12: 479-487.
76. van Dam, H., D. Wilhelm, I. Herr, A. Steffen, P. Herrlich, and P. Angel. 1995. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J. 14: 1798-1811.
77. 3 in HL60 cells. Cancer Res. 56: 264-267.
78. Whitmarsh, A.J., P. Shore, A.D. Sharrocks, and R.J. Davis. 1995. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269: 403-407.
79. Yan, M., T. Dai, J.C. Deak, J.M. Kyriakis, L.I. Zon, J.R. Woodgett, and D.J. Templeton. 1994. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature 372: 798-800.
80. Yang-Yen, H.F., J.C. Chambard, Y.L. Sun, T. Smeal, T.J. Schmidt, J. Drouin, and M. Karin. 1990. Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62: 1205-1215.
81. Yang-Yen, H.F., X. Zhang, G. Graupner, M. Tzukerman, B. Sakamoto, M. Karin, and M. Pfahl. 1991. Antagonism between retinoic acid receptors and AP-1: Implications for tumor promotion and inflammation. New Biol. 3: 1206-1219.
82. Zelent, A., A. Krust, M. Petkovich, P. Kastner, and P. Chambon. 1989. Cloning of murine α and β retinoic acid receptors and a novel receptor γ predominantly expressed in skin. Nature 339: 714-717.
83. Zhang, X.K., K.N. Wills, M. Husmann, T. Hermann, and M. Pfahl. 1991. Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities. Mol. Cell. Biol. 11: 6016-6025.
84. Zinck, R., R.A. Hipskind, V. Pingoud, and A. Nordheim. 1993. c-fos transcriptional activation and repression correlate temporally with the phosphorylation status of TCF. EMBO J. 12: 2377-2387.
85. Zinck, R., M.A. Cahill, M. Kracht, C. Sachsenmaier, R.A. Hipskind, and A. Nordheim. 1995. Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1. Mol. Cell. Biol. 15: 4930-4938.